A hedge fund where the Prime Minister, Rishi Sunak, was a founding partner, has seen its profits more than double in a year. Annual reports published on Companies House reveal that Theleme Partners made £109m in the year up to 31 March 2022 – a £65m increase from the previous year.
Theleme is heavily invested in Covid vaccine manufacturers Moderna – which last month signed a 10-year partnership with the UK Government for an undisclosed sum.
The Prime Minister left the company in 2013 in order to pursue his political career. However, he has refused to deny that he will profit from a surge in the share price of vaccine manufacturer Moderna and subsequent profits from Theleme.
The mystery is further compounded by the failure of the PM to publish his tax returns, despite promising to do so.